Search

Your search keyword '"Torrieri, Maria Claudia"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Torrieri, Maria Claudia" Remove constraint Author: "Torrieri, Maria Claudia"
122 results on '"Torrieri, Maria Claudia"'

Search Results

1. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

2. REVEALS—a longitudinal cohort study of multifaceted respiratory assessment in ALS.

6. Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS)

8. Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis

9. Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions

11. Respiratory support in a population-based ALS cohort: demographic, timing and survival determinants

12. The Use of Blood Carbonate (HCO3−) and Base-Excess (SBE) in Predicting Non-Invasive Ventilation (NIV) Adaptation (P1-1.Virtual)

13. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

14. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

17. Amyotrophic lateral sclerosis patients' quality of life and their caregiver burden during COVID-19 pandemic

19. Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers

20. Correlations between measures of ALS respiratory function: is there an alternative to FVC?

21. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

23. Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs

24. Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis

25. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

26. Correlations between measures of ALS respiratory function: is there an alternative to FVC?

27. Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic

29. Metabolic Brain Changes Across Different Levels Of Cognitive Impairment In ALS: A 18F-FDG-PET Study (4129)

31. Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers.

32. Can amyotrophic lateral sclerosis progression really pause? A cohort study using the medical research council scale.

34. Metabolic brain changes across different levels of cognitive impairment in ALS: a18F-FDG-PET study

35. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience

36. Validation of the Italian version of self-administered ALSFRS-R scale

37. The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring

38. Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs.

39. Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis

40. Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study

41. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience.

42. Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis.

43. Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study.

44. Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study

45. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: Additional findings from the randomized, sham-controlled, double-blind PRESTO trial 11 Medical and Health Sciences 1103 Clinical Sciences

46. Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study.

47. Amyotrophic lateral sclerosis caregiver burden and patients' quality of life during COVID-19 pandemic.

48. Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study

49. Validation of the Italian version of self-administered ALSFRS-R scale.

50. The Characteristics of Cognitive Impairment in ALS Patients Depend on the Lateralization of Motor Damage.

Catalog

Books, media, physical & digital resources